Natriumklorid Viaflo Baxter (Sodium Chloride)

Sodium chloride provides an isotonic fluid that expands the extracellular compartment. The sodium component raises plasma osmolality, drawing water from the intracellular space into the bloodstream, which increases intravascular volume and helps normalize serum sodium levels, supporting tissue perfusion and cellular function.

The dose of Natriumklorid Viaflo Baxter is individualized by the prescribing clinician based on the patient’s fluid loss, current electrolyte status, body weight, and clinical condition. Healthcare professionals calculate the required volume and infusion rate to achieve safe and effective fluid replacement.

Safety data for Natriumklorid Viaflo Baxter in pregnancy and lactation are limited. Because it is a sterile saline solution, it is generally considered low risk, but clinicians should weigh potential benefits against any unknown risks and monitor maternal and fetal status closely.

To order Natriumklorid Viaflo Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Natriumklorid Viaflo Baxter is a standard isotonic (0.9% NaCl) solution, comparable to other normal saline products on the market. Its composition and clinical effects are similar, but differences may exist in packaging, sterility assurance, and regulatory compliance. GNH India ensures EU‑grade quality and GDP compliance for reliable supply.

The product should be stored at 2‑8 °C, protected from light, and kept in its original container. It must not be frozen or shaken vigorously. Maintaining the cold‑chain ensures solution stability and sterility until the point of use.

Natriumklorid Viaflo Baxter is administered intravenously. The solution is typically infused through a peripheral or central venous line, with the rate determined by the clinical situation. Infusion sets and compatible IV equipment should be used, and the line should be monitored for signs of infiltration or phlebitis.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare anaphylactic reactions. Clinicians should monitor serum sodium, fluid balance, and respiratory status, especially in patients with cardiac, renal, or pulmonary disease, and adjust therapy promptly if adverse signs appear.

Patients with known hypersensitivity to sodium chloride solutions should avoid this product. Caution is advised for individuals with severe renal impairment, uncontrolled heart failure, or conditions predisposing them to fluid overload, as excessive administration may exacerbate these disorders.